Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Unipolare Depression Langfassung - Versorgungsleitlinien.de
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
497. Thase ME, Greenhouse JB, Frank E, Reynolds CF, III, Pilkonis PA, Hurley K, Grochocinski V,<br />
Kupfer DJ. Treatment of major <strong>de</strong>pression with psychotherapy or psychotherapypharmacotherapy<br />
combinations. Arch Gen Psychiatry 1997;54(11):1009-15.<br />
498. Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC,<br />
Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone,<br />
the cognitive behavioral-analysis system of psychotherapy, and their combination for the<br />
treatment of chronic <strong>de</strong>pression. N Engl J Med 2000;342(20):1462-70.<br />
499. Sutej I, Wiethoff K, Neuhaus K, Bauer M. Pharmakotherapie und Psychotherapie bei<br />
unipolarer <strong>Depression</strong>. Ist die kombinierte Behandlung einer Monotherapie überlegen? Z<br />
Psychia Psych Psychother 2006;54(3):163-72.<br />
500. Burnand Y, Andreoli A, Kolatte E, Venturini A, Rosset N. Psychodynamic psychotherapy and<br />
clomipramine in the treatment of major <strong>de</strong>pression. Psychiatr Serv 2002;53(5):585-90.<br />
501. <strong>de</strong> Jong-Meyer R, Hautzinger M, Rudolf G, Strauß W, Frick U. Die Überprüfung <strong>de</strong>r<br />
Wirksamkeit einer Kombination von Anti<strong>de</strong>pressiva- und Verhaltenstherapie bei endogen<br />
<strong>de</strong>pressiven Patienten: Varianzanalytische Ergebnisse zu <strong>de</strong>n Haupt- und Nebenkriterien <strong>de</strong>s<br />
Therapieerfolgs. Z Klin Psych 1996;25(2):93-109.<br />
502. <strong>de</strong> Jonghe F, Hendricksen M, van Aalst G, Kool S, Peen V, Van R, van <strong>de</strong>n Eijn<strong>de</strong>n E, Dekker<br />
J. Psychotherapy alone and combined with pharmacotherapy in the treatment of <strong>de</strong>pression.<br />
Br J Psychiatry 2004;185:37-45.<br />
503. Mynors-Wallis LM, Gath DH, Day A, Baker F. Randomised controlled trial of problem solving<br />
treatment, anti<strong>de</strong>pressant medication, and combined treatment for major <strong>de</strong>pression in<br />
primary care. BMJ 2000;320(7226):26-30.<br />
504. Hautzinger M, <strong>de</strong> Jong-Meyer R, Treiber R, Rudolf G, Thien U. Wirksamkeit kognitiver<br />
Verhaltenstherapie, Pharmakotherapie und <strong>de</strong>ren Kombination bei nicht-endogenen<br />
unipolaren <strong>Depression</strong>en. Z Klin Psych 1996;25:130-45.<br />
505. Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic anti<strong>de</strong>pressants: a<br />
meta-analysis and investigation of heterogeneity. Br J Psychiatry 1997;170:120-7.<br />
506. Agency for Health Care Policy and Research (AHCPR). Treatment of <strong>Depression</strong>. Newer<br />
Pharmacotherapies. Evi<strong>de</strong>nce Report/Technology Assessment No. 7. 1999 [cited: 2006 Jul<br />
05]. Available from: http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.9286<br />
507. Trinda<strong>de</strong> E, Menon D, Topfer LA, Coloma C. Adverse effects associated with selective<br />
serotonin reuptake inhibitors and tricyclic anti<strong>de</strong>pressants: a meta-analysis. CMAJ<br />
1998;159(10):1245-52.<br />
508. Barbui C, Guaiana G, Hotopf M. Amitriptyline for inpatients and SSRIs for outpatients with<br />
<strong>de</strong>pression? Systematic review and meta-regression analysis. Pharmacopsychiatry<br />
2004;37(3):93-7.<br />
509. Wilson K, Mottram P. A comparison of si<strong>de</strong> effects of selective serotonin reuptake inhibitors<br />
and tricyclic anti<strong>de</strong>pressants in ol<strong>de</strong>r <strong>de</strong>pressed patients: a meta-analysis. Int J Geriatr<br />
Psychiatry 2004;19(8):754-62.<br />
510. Brambilla P, Cipriani A, Hotopf M, Barbui C. Si<strong>de</strong>-effect profile of fluoxetine in comparison with<br />
other SSRIs, tricyclic and newer anti<strong>de</strong>pressants: a meta-analysis of clinical trial data.<br />
Pharmacopsychiatry 2005;38(2):69-77.<br />
511. Degner D, Grohmann R, Kropp S, Ruther E, Ben<strong>de</strong>r S, Engel RR, Schmidt LG. Severe<br />
adverse drug reactions of anti<strong>de</strong>pressants: results of the German multicenter drug<br />
surveillance program AMSP. Pharmacopsychiatry 2004;37 Suppl 1:S39-S45.<br />
512. Ackerman DL, Greenland S. Multivariate meta-analysis of controlled drug studies for<br />
obsessive-compulsive disor<strong>de</strong>r. J Clin Psychopharmacol 2002;22(3):309-17.<br />
513. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, Newcorn J, Sallee FR,<br />
Sangal RB, Saylor K, West S, Kelsey D, Wernicke J, Trapp NJ, Har<strong>de</strong>r D. Once-daily<br />
atomoxetine treatment for children and adolescents with attention <strong>de</strong>ficit hyperactivity<br />
disor<strong>de</strong>r: a randomized, placebo-controlled study. Am J Psychiatry 2002;159(11):1896-901.<br />
514. Furukawa TA, Streiner DL, Young LT, Kinoshita Y. Anti<strong>de</strong>pressants plus benzodiazepines for<br />
major <strong>de</strong>pression. Cochrane Database Syst Rev 2004;2.<br />
© 2009 226
Change language